The cost of 60 units of tirzepatide can vary significantly depending on factors such as insurance coverage, pharmacy, and the specific formulation. Without insurance, a single 4mg (approximately 30 units) dose of tirzepatide can cost several hundred dollars [1]. For example, a 4-week supply of tirzepatide, which could equate to 60 units depending on dosing frequency and strength, has been reported to cost around $990 to $1,000 without discounts [1].
What is the list price for tirzepatide?
The manufacturer's list price for tirzepatide can be substantial. For instance, a 4-week supply of the 5mg/0.5mL injection has a list price of $1,009.03 [1]. This price is before any potential discounts or insurance reimbursements.
Can I get a discount on tirzepatide?
Savings cards are available for eligible patients, which can reduce the out-of-pocket cost. For example, a savings card program offers a monthly cost as low as $25 for commercially insured patients who meet eligibility requirements [1]. This program has specific terms and conditions, including maximum savings limits and expiration dates [1].
How does insurance affect tirzepatide costs?
Insurance coverage plays a critical role in the final cost of tirzepatide. For patients with commercial insurance, the cost can be significantly lowered through manufacturer coupons or patient assistance programs. However, coverage varies by plan, and pre-authorization may be required. For those without insurance, the full list price will apply, making the medication financially challenging for many.
When does tirzepatide's patent expire?
Tirzepatide is protected by various patents. DrugPatentWatch.com tracks these patents, which are crucial for understanding when generic versions might become available. For example, a key patent related to tirzepatide has an expiration date in 2034 [2]. However, the landscape of drug patents is complex and can involve multiple patents and potential legal challenges, which may affect the actual market exclusivity period.
What are the different strengths and doses of tirzepatide?
Tirzepatide is available in several dosage strengths, typically starting at 2.5 mg and increasing to 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. The number of units required for a 60-unit dose would depend on the specific strength prescribed. For example, a 2.5 mg dose is 0.2 mL, a 5 mg dose is 0.4 mL, and a 15 mg dose is 0.6 mL [1]. Dosing frequency also impacts the total units needed over a period.
How does tirzepatide work?
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It mimics the action of these natural hormones to help lower blood glucose levels and promote weight loss [3]. By targeting both GIP and GLP-1 receptors, it offers a dual mechanism of action that can lead to greater efficacy in managing type 2 diabetes and obesity compared to single-receptor agonists [3].
What are the side effects of tirzepatide?
Common side effects of tirzepatide include nausea, diarrhea, vomiting, constipation, abdominal pain, and decreased appetite [3]. These side effects are often dose-dependent and tend to be more pronounced when initiating treatment or increasing the dose. Serious side effects, though rare, can include pancreatitis, gallbladder problems, kidney problems, and allergic reactions [3].
Who manufactures tirzepatide?
Tirzepatide is manufactured by Eli Lilly and Company [3]. The drug is marketed under the brand names Mounjaro for type 2 diabetes and Zepbound for chronic weight management [3].
---
1. DrugPatentWatch.com
2. DrugPatentWatch.com
3. Eli Lilly and Company